Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at standard treatment with or without celecoxib for transitional cell bladder cancer (BOXIT)

Overview

Cancer types:

Bladder cancer, Transitional cell cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at celecoxib for a very early type of bladder cancer called superficial transitional cell bladder cancer. It was supported by Cancer Research UK.

Recruitment start: 1 November 2007

Recruitment end: 23 July 2012

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof. J Kelly

Supported by

Cambridge Laboratories

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Kyowa Hakko UK Limited

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/07/004.

Last reviewed: 04 Sept 2019

CRUK internal database number: 539

Help and support